1. Home
  2. TMCI

TMCI

Treace Medical Concepts Inc.

Logo Treace Medical Concepts Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

Founded: 2014 Country:
United States
United States
Employees: N/A City: PONTE VEDRA
Market Cap: 698.0M IPO Year: 2021
Target Price: $19.58 AVG Volume (30 days): 413.2K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.81 EPS Growth: N/A
52 Week Low/High: $5.27 - $27.70 Next Earning Date: 05-07-2024
Revenue: $187,118,000 Revenue Growth: 31.92%
Revenue Growth (this year): 21.46% Revenue Growth (next year): 18.08%

Share on Social Networks: